Investing.com - Fresenius Medical Care ADR reported on Friday second quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Fresenius Medical Care ADR announced earnings per share of $0.4516 on revenue of $5.13B. Analysts polled by Investing.com anticipated EPS of $0.4804 on revenue of $5.22B.
Fresenius Medical Care ADR shares are down 2% from the beginning of the year and are trading at $39.53 , down-from-52-week-high.They are under-performing the STOXX 600 which is up 15.72% from the start of the year.
Fresenius Medical Care ADR shares lost 4.22% in pre-market trade the report.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by J&J on Wednesday, July 21, 2021, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on Thursday, July 15, 2021 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar